Sodium Polystyrene Sulfonate
These highlights do not include all the information needed to use SODIUM POLYSTYRENE SULFONATE FOR SUSPENSION safely and effectively. See full prescribing information for SODIUM POLYSTYRENE SULFONATE FOR SUSPENSION SODIUM POLYSTYRENE SULFONATE FOR SUSPENSION, for oral or rectal use Initial U.S. Approval: 1958
Approved
Approval ID
2017bfbe-cda8-46f1-b4f1-9c086c3249a9
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 1, 2021
Manufacturers
FDA
CMP Pharma, Inc.
DUNS: 005224175
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Sodium Polystyrene Sulfonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code46287-012
Application NumberANDA089910
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sodium Polystyrene Sulfonate
Product Specifications
Route of AdministrationORAL, RECTAL
Effective DateNovember 30, 2017
FDA Product Classification
INGREDIENTS (1)
SODIUM POLYSTYRENE SULFONATEActive
Quantity: 1 g in 1 g
Code: 1699G8679Z
Classification: ACTIB